CFLAR and neoplasm: Keeping in mind that extensive research is being pursued worldwide to use TRAIL or TRAIL derivatives in the clinic and that c-FLIP isoforms are often highly expressed in tumor cells,7 inhibiting c-FLIP solubility with locally applied or whole-body hyperthermia could be relevant to cancer TRAIL-based therapies.2, 17